Association of endothelin-1 gene variant with hypertension

被引:87
作者
Jin, JJ [1 ]
Nakura, J [1 ]
Wu, ZH [1 ]
Yamamoto, M [1 ]
Abe, M [1 ]
Tabara, Y [1 ]
Yamamoto, Y [1 ]
Igase, M [1 ]
Kohara, K [1 ]
Miki, T [1 ]
机构
[1] Ehime Univ, Sch Med, Dept Geriatr Med, Shigenobu, Ehime 7910295, Japan
关键词
endothelin; hypertension; essential; genetics; polymorphism; body mass index;
D O I
10.1161/01.HYP.0000043680.75107.CF
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Endothelin-1 (ET-1) is a powerful vasoconstrictor peptide produced by endothelial and smooth muscle cells. Many lines of biological evidence suggest that the ET-1 gene is a candidate gene for hypertension. Moreover, recent association studies suggested that a G/T polymorphism with an amino acid substitution (Lys/Asn) at codon 198 in exon 5 of the ET-1 gene interacts with body mass index (BMI) in association with blood pressure. They suggested that T carriers are more sensitive to weight gain than GG homozygotes in association with blood pressure. However, association studies are often irreproducible, and the first study often suggests a stronger genetic effect than is found by subsequent studies. We therefore assessed the interaction in 2 large Japanese populations. The present study showed a nonsignificant but similar trend to the results of previous reports. Moreover, in line with previous reports, this study revealed a significant interaction between the ET-1 K198N (G/T) polymorphism and BMI in association with hypertension in our populations (P=0.027). The interaction was significant, even after adjustment for gender and age (P=0.045) and for all confounding factors (P=0.044). T carriers were more sensitive to weight gain than GG homozygotes in association with hypertension. Considering the combined impact of obesity and hypertension on the development of cardiovascular and cerebrovascular disorders, T allele carriers might represent elective targets for therapy to lower their body weight.
引用
收藏
页码:163 / 167
页数:5
相关论文
共 14 条
[1]   Endothelin-1 gene variant associates with blood pressure in obese Japanese subjects - The Ohasama study [J].
Asai, T ;
Ohkubo, T ;
Katsuya, T ;
Higaki, J ;
Fu, YX ;
Fukuda, M ;
Hozawa, A ;
Matsubara, M ;
Kitaoka, H ;
Tsuji, I ;
Araki, T ;
Satoh, H ;
Hisamichi, S ;
Imai, Y ;
Ogihara, T .
HYPERTENSION, 2001, 38 (06) :1321-1324
[2]   Racial differences in plasma endothelin-1 concentrations in individuals with essential hypertension [J].
Ergul, S ;
Parish, DC ;
Puett, D ;
Ergul, A .
HYPERTENSION, 1996, 28 (04) :652-655
[3]   PLASMA ENDOTHELIN-1 LEVELS IN OBESE HYPERTENSIVE AND NORMOTENSIVE MEN [J].
FERRI, C ;
BELLINI, C ;
DESIDERI, G ;
DIFRANCESCO, L ;
BALDONCINI, R ;
SANTUCCI, A ;
DEMATTIA, G .
DIABETES, 1995, 44 (04) :431-436
[4]   Replication validity of genetic association studies [J].
Ioannidis, JPA ;
Ntzani, EE ;
Trikalinos, TA ;
Contopoulos-Ioannidis, DG .
NATURE GENETICS, 2001, 29 (03) :306-309
[5]   The effect of an endothelin-receptor antagonist, bosentan, on blood pressure in patients with essential hypertension [J].
Krum, H ;
Viskoper, RJ ;
Lacourciere, Y ;
Budde, M ;
Charlon, V .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (12) :784-790
[6]  
LEMNE CE, 1994, J HYPERTENS, V12, P1069
[7]   Central obesity and hypertension - The role of plasma endothelin [J].
Parrinello, G ;
Scaglione, R ;
Pinto, A ;
Corrao, S ;
Cecala, M ;
DiSilvestre, G ;
Amato, P ;
Licata, A ;
Licata, G .
AMERICAN JOURNAL OF HYPERTENSION, 1996, 9 (12) :1186-1191
[8]   Enhanced expression of endothelin-1 gene in resistance arteries in severe human essential hypertension [J].
Schiffrin, EL ;
Deng, LY ;
Sventek, P ;
Day, R .
JOURNAL OF HYPERTENSION, 1997, 15 (01) :57-63
[9]   PLASMA ENDOTHELIN IN HUMAN ESSENTIAL-HYPERTENSION [J].
SCHIFFRIN, EL ;
THIBAULT, G .
AMERICAN JOURNAL OF HYPERTENSION, 1991, 4 (04) :303-308
[10]   PLASMA ENDOTHELIN LEVELS IN HYPERTENSION AND CHRONIC-RENAL-FAILURE [J].
SHICHIRI, M ;
HIRATA, Y ;
ANDO, K ;
EMORI, T ;
OHTA, K ;
KIMOTO, S ;
OGURA, M ;
INOUE, A ;
MARUMO, F .
HYPERTENSION, 1990, 15 (05) :493-496